Theoretical design demonstrates Z-scheme photocatalyst achieves 14.296% STH efficiency, improving carrier separation.
BIEF & band bending force exclusive path 2 recombination, proving Z-scheme. This boosts carrier separation while preserving strong redox power. ZnTe side is HER site, ZrS 2 OER site. ZnTe/ZrS 2 heterojunction achieves 14.296% STH efficiency.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: